301 related articles for article (PubMed ID: 20940143)
21. Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia.
Verlekar D; Wei SJ; Cho H; Yang S; Kang MH
Cell Death Dis; 2018 Sep; 9(9):925. PubMed ID: 30206207
[TBL] [Abstract][Full Text] [Related]
22. Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the Tram-Lag-CLN8 (TLC) domain.
Tidhar R; Ben-Dor S; Wang E; Kelly S; Merrill AH; Futerman AH
J Biol Chem; 2012 Jan; 287(5):3197-206. PubMed ID: 22144673
[TBL] [Abstract][Full Text] [Related]
23. GPER1 influences cellular homeostasis and cytostatic drug resistance via influencing long chain ceramide synthesis in breast cancer cells.
Wegner MS; Gruber L; Schömel N; Trautmann S; Brachtendorf S; Fuhrmann D; Schreiber Y; Olesch C; Brüne B; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2019 Jul; 112():95-106. PubMed ID: 31082617
[TBL] [Abstract][Full Text] [Related]
24. 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length.
Mizutani Y; Kihara A; Chiba H; Tojo H; Igarashi Y
J Lipid Res; 2008 Nov; 49(11):2356-64. PubMed ID: 18541923
[TBL] [Abstract][Full Text] [Related]
25. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
[TBL] [Abstract][Full Text] [Related]
26. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
Park JW; Park WJ; Futerman AH
Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
[TBL] [Abstract][Full Text] [Related]
27. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
Jang Y; Rao X; Jiang Q
J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
[TBL] [Abstract][Full Text] [Related]
28. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species.
Montgomery MK; Brown SH; Lim XY; Fiveash CE; Osborne B; Bentley NL; Braude JP; Mitchell TW; Coster AC; Don AS; Cooney GJ; Schmitz-Peiffer C; Turner N
Biochim Biophys Acta; 2016 Nov; 1861(11):1828-1839. PubMed ID: 27591968
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides.
Kihara A
Prog Lipid Res; 2016 Jul; 63():50-69. PubMed ID: 27107674
[TBL] [Abstract][Full Text] [Related]
30. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis.
Stiban J; Perera M
Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172
[TBL] [Abstract][Full Text] [Related]
31. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.
Pewzner-Jung Y; Park H; Laviad EL; Silva LC; Lahiri S; Stiban J; Erez-Roman R; Brügger B; Sachsenheimer T; Wieland F; Prieto M; Merrill AH; Futerman AH
J Biol Chem; 2010 Apr; 285(14):10902-10. PubMed ID: 20110363
[TBL] [Abstract][Full Text] [Related]
32. Transcript profiling and lipidomic analysis of ceramide subspecies in mouse embryonic stem cells and embryoid bodies.
Park H; Haynes CA; Nairn AV; Kulik M; Dalton S; Moremen K; Merrill AH
J Lipid Res; 2010 Mar; 51(3):480-9. PubMed ID: 19786568
[TBL] [Abstract][Full Text] [Related]
33. Generation of a ceramide synthase 6 mouse lacking the DDRSDIE C-terminal motif.
Kim J; Pewzner-Jung Y; Joseph T; Ben-Dor S; Futerman AH
PLoS One; 2022; 17(7):e0271675. PubMed ID: 35849604
[TBL] [Abstract][Full Text] [Related]
34. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth.
Hartmann D; Lucks J; Fuchs S; Schiffmann S; Schreiber Y; Ferreirós N; Merkens J; Marschalek R; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2012 Apr; 44(4):620-8. PubMed ID: 22230369
[TBL] [Abstract][Full Text] [Related]
35. Ceramide synthase-dependent ceramide generation and programmed cell death: involvement of salvage pathway in regulating postmitochondrial events.
Mullen TD; Jenkins RW; Clarke CJ; Bielawski J; Hannun YA; Obeid LM
J Biol Chem; 2011 May; 286(18):15929-42. PubMed ID: 21388949
[TBL] [Abstract][Full Text] [Related]
36. Changes in membrane biophysical properties induced by sphingomyelinase depend on the sphingolipid N-acyl chain.
Pinto SN; Laviad EL; Stiban J; Kelly SL; Merrill AH; Prieto M; Futerman AH; Silva LC
J Lipid Res; 2014 Jan; 55(1):53-61. PubMed ID: 24163422
[TBL] [Abstract][Full Text] [Related]
37. The effect of altered sphingolipid acyl chain length on various disease models.
Park WJ; Park JW
Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
[TBL] [Abstract][Full Text] [Related]
38. Ceramide synthases in biomedical research.
Cingolani F; Futerman AH; Casas J
Chem Phys Lipids; 2016 May; 197():25-32. PubMed ID: 26248326
[TBL] [Abstract][Full Text] [Related]
39. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
40. Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides.
Trayssac M; Clarke CJ; Stith JL; Snider JM; Newen N; Gault CR; Hannun YA; Obeid LM
Cell Death Dis; 2021 Jan; 12(1):27. PubMed ID: 33414460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
